Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study finds autism and mental retardation markers:

This article was originally published in Clinica

Executive Summary

A US team has discovered a link between markers in neonatal blood and the likelihood of developing autism or mental retardation later in childhood. In an examination of archived neonatal blood, researchers found significantly elevated levels of several neuronal growth factors only in children who went on to develop autism or mental retardation, study researcher Judith Grether reports in the Annals of Neurology (May). Identifying a biological marker early in life and before the onset of symptoms could lead to earlier and more definitive diagnoses and lead to the discovery of interventional therapies for the disorders.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070904

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel